BioCentury
ARTICLE | Clinical News

Humira adalimumab regulatory update

September 10, 2012 7:00 AM UTC

Abbott and partner Eisai said Japan's Ministry of Health, Labor and Welfare (MHLW) approved a regulatory application to extend the label of Humira adalimumab to include inhibition of structural joint ...